Alzheimer's Disease: Combination Therapies and Clinical Trials for Combination Therapy Development.
- Published in:
- CNS Drugs, 2024, v. 38, n. 8, p. 613, doi. 10.1007/s40263-024-01103-1
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2024 AND VI 38 AND IP 8
Results: 6
1
2
A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.
- Published in:
- CNS Drugs, 2024, v. 38, n. 8, p. 625, doi. 10.1007/s40263-024-01102-2
- By:
- Publication type:
- Article
3
The Use of Ketamine for the Treatment of Anhedonia in Depression.
- Published in:
- CNS Drugs, 2024, v. 38, n. 8, p. 583, doi. 10.1007/s40263-024-01099-8
- By:
- Publication type:
- Article
4
The State of Synthetic Cannabinoid Medications for the Treatment of Pain.
- Published in:
- CNS Drugs, 2024, v. 38, n. 8, p. 597, doi. 10.1007/s40263-024-01098-9
- By:
- Publication type:
- Article
5
Sex Differences in the Dual Antiplatelet Therapy Versus Alteplase for Patients with Minor Nondisabling Acute Ischemic Stroke: A Secondary Analysis of the ARAMIS Study.
- Published in:
- CNS Drugs, 2024, v. 38, n. 8, p. 649, doi. 10.1007/s40263-024-01096-x
- By:
- Publication type:
- Article
6
Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population.
- Published in:
- CNS Drugs, 2024, v. 38, n. 8, p. 637, doi. 10.1007/s40263-024-01094-z
- By:
- Publication type:
- Article